Argentina

Convalescent Plasma Flunks Study in Covid-19 Patients with Severe Pneumonia

Argentina, Convalescent Plasma, COVID-19 Infections, Covid-19 Pneumonia, COVID-19 Studies, Emergency Use Authorization, FDA, Mortality, R&D, SARS-CoV-2 virus, The New England Journal of Medicine (NEJM), U.S. Health Secretary Alex Azar

A study showed the use of convalescent plasma provided no clinical benefit nor improved mortality in Covid-19 patients with pneumonia.

November 25, 2020/by BioSpace

Plasma from recovered patients shows little benefit in those hospitalized with Covid-19: study

Antibodies, Argentina, Blood Plasma, Clinical Trials, Convalescent Plasma, Covid-19 Pneumonia, COVID-19 Studies, Donald Trump, Hospitalized COVID-19 Patients, India, New England Journal of Medicine, R&D, Researchers, Symptoms: Coronavirus Disease 2019 (COVID-19)

Using blood plasma from Covid-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released from a clinical trial in Argentina.

November 24, 2020/by Reuters Health